China NMPA Product Recall - Ventilator

On August 7, 2025, the National Medical Products Administration (NMPA) issued a notice concerning a Class II voluntary recall of specific Ventilator ventilators manufactured by Respironics, Inc. This recall was formally reported by Philips (China) Investment Co., Ltd., acting on behalf of the manufacturer. The primary issue prompting this action was the failure of some of these medical products during essential service testing, indicating they did not meet specified performance or safety standards. The affected devices are identified by National Medical Device Registration Certificate No. 201720. Under the regulatory authority of the NMPA, Respironics, Inc. initiated this voluntary recall to address these identified product deficiencies. A crucial detail highlighted in the report is that none of the products implicated in this particular recall event were imported into China, suggesting the recall primarily impacts other international markets where these ventilators were distributed. The required action involves removing these non-compliant ventilators from distribution to mitigate any potential health risks to users. Detailed information concerning the specific models, specifications, and batch numbers involved is contained within the 'Medical Device Recall Event Report Form.' This action exemplifies the stringent oversight and commitment to medical device quality and patient safety maintained within the regulatory framework.